at Ferring, we define ourselves with a single word.
the health of people comes first
We research, develop, manufacture and market products that work on the body’s own terms to help health care providers combat a wide range of diseases and medical conditions.
Ferring US issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency Learn More
FERRING STATEMENT ON THE IMPACT OF COVID-19 PANDEMIC ON PRODUCT AND SUPPLY Learn more
Ferring Statement on the COVID-19 (novel coronavirus disease) Pandemic and Reproductive Medicine Learn more
@FerringUSA on TwitterDID YOU NOW: #cdiff infection is a major public health threat according to the #CDC and can be life-threatening. A recent research letter (N=9) found that patients with #coronavirus and #cdiff had a 44% mortality rate. #MicrobiomeMonday #FerringMicrobiome
Public Policy Statement:
Proposed Legislation to Improve Price Transparency and Better Serve the Patient, the Taxpayer and the Physician.
WASHINGTON D.C. December 5, 2019 – FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced today positive results from the pivotal Phase 3 clinical trial evaluating nadofaragene firadenovec (rAd-IFN/Syn3), an investigational gene therapy, for the treatment of high-grade, Bacillus Calmette-Guérin (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC).
Find out what’s new at Ferring Pharmaceuticals.
View More Press Releases >
passionate people come first to Ferring
What kind of people succeed at Ferring? People who are smart. Curious. Ambitious. People who want to do well. And do good.
Carers. Sharers. Darers.